Wayne Forrest[email protected]Clinical NewsMRI contrast: Unnecessary for follow-up in meningioma?In the routine follow-up of patients with intracranial meningioma, unenhanced MRI scans are as effective in evaluating the disease as imaging with gadolinium contrast, according to a study from Turkey presented at ECR 2018 in Vienna.April 4, 2018Clinical NewsNovel PET agent could advance neurological imagingSwiss and German researchers have obtained promising results with a novel PET imaging agent that could help guide and assess treatment for people with various neurological diseases. The preclinical study was published in the April issue of the Journal of Nuclear Medicine.April 2, 2018Clinical NewsAre EMF levels acceptable in mobile MRI units?An analysis of mobile MRI scanners in the U.K. shows compliance with standards for safe electromagnetic field (EMF) exposure for full-time clinical staff, but training should be implemented to further reduce exposure during the working week and when imaging patients.April 2, 2018Clinical NewsPRECISION trial lauds MRI for prostate cancer detectionWith its ability to accurately detect more malignant prostate cancer lesions than transrectal ultrasound-guided biopsy, multiparametric MRI can reduce the frequency of the invasive procedures by as much as 28%, according to a multicenter, international study presented last week.March 25, 2018Clinical NewsMRI can advance soft-tissue sarcoma evaluationBy targeting certain biomarkers, conventional MRI scans can help accurately classify soft-tissue sarcoma after core needle biopsy, according to a French study presented at ECR 2018 in Vienna.March 22, 2018Molecular ImagingAuntMinnieEurope.com Molecular Imaging InsiderMarch 19, 2018Clinical NewsPET/MRI, PET/CT can add to initial breast cancer stagingBoth PET/MRI and PET/CT perform admirably in the initial staging of breast cancer patients, but there are subtle nuances between the hybrid modalities of which clinicians should be aware, according to a Swiss study presented earlier this month at ECR 2018 in Vienna.March 19, 2018Clinical NewsKey PET factors help assess Hodgkin's lymphoma outcomeCertain quantitative PET parameters can help clinicians predict how well patients with Hodgkin's lymphoma will react to their treatment, according to preliminary results from a study conducted in the Ukraine and presented at ECR 2018 in Vienna.March 18, 2018Clinical NewsPET/MRI falls short in lymph node metastases analysisWhile the combination of PET and MRI has shown promise for detecting and characterizing some forms of cancer, the hybrid modality does not match the accuracy of invasive sentinel lymph node biopsy in melanoma patients, according to a study presented at ECR 2018 in Vienna.March 15, 2018ConferenceESNR survey taps into future of imaging for dementiaVIENNA - While there is considerable consensus on which modalities and protocols to use to diagnose dementia, few neuroradiologists feel comfortable using advanced imaging, structured reports, or visual rating scales, according to survey results from the European Society of Neuroradiology (ESNR) presented on Saturday at ECR 2018.March 3, 2018Previous PagePage 13 of 46Next PageTop StoriesCTStudy: Keep aware of hydrophilic polymer embolizationClinicians, vendors, and regulators must collaborate to prevent hydrophilic polymer embolization, an underdiagnosed complication of endovascular interventions, European researchers have asserted.CTRadiology mourns death of Ireland’s Barry KellyArtificial IntelligenceAI improves MRI diagnosis of prostate cancerHomeHow can we minimize errors caused by human factors?Sponsor ContentJoin us 26 June at 6 p.m. CET for a FREE webinar!